# An Innovative Treatment for Cervical Precancer (UH3)

> **NCT03084081** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 1132 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DEVICE:** CO2 standard therapy
- **DEVICE:** CryoPen
- **DEVICE:** Thermocoagulator

## Key facts

- **NCT ID:** NCT03084081
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 1132 (ACTUAL)
- **Last updated:** 2025-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084081, "An Innovative Treatment for Cervical Precancer (UH3)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03084081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*